These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27340345)

  • 1. A H 2 S Donor GYY4137 Exacerbates Cisplatin-Induced Nephrotoxicity in Mice.
    Liu M; Jia Z; Sun Y; Zhang A; Yang T
    Mediators Inflamm; 2016; 2016():8145785. PubMed ID: 27340345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polysulfide and Hydrogen Sulfide Ameliorate Cisplatin-Induced Nephrotoxicity and Renal Inflammation through Persulfidating STAT3 and IKKβ.
    Sun HJ; Leng B; Wu ZY; Bian JS
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The route and timing of hydrogen sulfide therapy critically impacts intestinal recovery following ischemia and reperfusion injury.
    Jensen AR; Drucker NA; Te Winkel JP; Ferkowicz MJ; Markel TA
    J Pediatr Surg; 2018 Jun; 53(6):1111-1117. PubMed ID: 29622397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice.
    Kaya-Yasar Y; Karaman Y; Bozkurt TE; Onder SC; Sahin-Erdemli I
    Pulm Pharmacol Ther; 2017 Aug; 45():170-180. PubMed ID: 28645584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily therapy with a slow-releasing H
    Lin S; Lian D; Liu W; Haig A; Lobb I; Hijazi A; Razvi H; Burton J; Whiteman M; Sener A
    Nitric Oxide; 2018 Jun; 76():16-28. PubMed ID: 29522906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GYY4137, an Extended-Release Hydrogen Sulfide Donor, Reduces NMDA-Induced Neuronal Injury in the Murine Retina.
    Sone K; Mori A; Sakamoto K; Nakahara T
    Biol Pharm Bull; 2018; 41(4):657-660. PubMed ID: 29607941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betaine supplementation mitigates cisplatin-induced nephrotoxicity by abrogation of oxidative/nitrosative stress and suppression of inflammation and apoptosis in rats.
    Hagar H; Medany AE; Salam R; Medany GE; Nayal OA
    Exp Toxicol Pathol; 2015 Feb; 67(2):133-41. PubMed ID: 25488130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen sulfide alleviates hypertensive kidney dysfunction through an epigenetic mechanism.
    Weber GJ; Pushpakumar SB; Sen U
    Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H874-H885. PubMed ID: 28213404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat.
    Li L; Salto-Tellez M; Tan CH; Whiteman M; Moore PK
    Free Radic Biol Med; 2009 Jul; 47(1):103-13. PubMed ID: 19375498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rg5 Ameliorates Cisplatin-Induced Nephrotoxicity in Mice through Inhibition of Inflammation, Oxidative Stress, and Apoptosis.
    Li W; Yan MH; Liu Y; Liu Z; Wang Z; Chen C; Zhang J; Sun YS
    Nutrients; 2016 Sep; 8(9):. PubMed ID: 27649238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antihypertension effect of hydrogen sulfide (H
    Zhu ML; Zhao FR; Zhu TT; Wang QQ; Wu ZQ; Song P; Xu J; Wan GR; Yin YL; Li P
    Life Sci; 2021 Feb; 267():118831. PubMed ID: 33253721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is hydrogen sulfide a potential novel therapy to prevent renal damage during ureteral obstruction?
    Lin S; Juriasingani S; Sener A
    Nitric Oxide; 2018 Feb; 73():15-21. PubMed ID: 29269061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Protective Effect of Hydrogen Sulfide in Cisplatin-Induced Nephrotoxicity.
    Cao X; Xiong S; Zhou Y; Wu Z; Ding L; Zhu Y; Wood ME; Whiteman M; Moore PK; Bian JS
    Antioxid Redox Signal; 2018 Aug; 29(5):455-470. PubMed ID: 29316804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Effects of GYY4137 on Renal Ischaemia/Reperfusion Injury through Nrf2-Mediated Antioxidant Defence.
    Zhao H; Qiu Y; Wu Y; Sun H; Gao S
    Kidney Blood Press Res; 2021; 46(3):257-265. PubMed ID: 33910212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H
    Yurinskaya MM; Krasnov GS; Kulikova DA; Zatsepina OG; Vinokurov MG; Chuvakova LN; Rezvykh AP; Funikov SY; Morozov AV; Evgen'ev MB
    Inflamm Res; 2020 May; 69(5):481-495. PubMed ID: 32157318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen sulfide donors prevent lipopolysaccharide-induced airway hyperreactivity in an in vitro model of chronic inflammation in mice.
    Karaman Y; Kaya-Yasar Y; Bozkurt TE; Sahin-Erdemli I
    Basic Clin Pharmacol Toxicol; 2021 May; 128(5):652-660. PubMed ID: 33369105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Inhibition of Caspase-1 Ameliorates Cisplatin-Induced Nephrotoxicity through Suppression of Apoptosis, Oxidative Stress, and Inflammation in Mice.
    Kim JY; Park JH; Kim K; Jo J; Leem J; Park KK
    Mediators Inflamm; 2018; 2018():6571676. PubMed ID: 30670928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of the Donor of Hydrogen Sulfide GYY4137 on the Activation of Human Neutrophils by E. coli Lipopolysaccharides].
    Petrushanko IY; Melnikova EV; Yurinskaya MM; Vinokurov MG; Suslikov AV; Mitkevich VA; Makarov AA
    Mol Biol (Mosk); 2019; 53(1):101-108. PubMed ID: 30895957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide.
    Li L; Whiteman M; Guan YY; Neo KL; Cheng Y; Lee SW; Zhao Y; Baskar R; Tan CH; Moore PK
    Circulation; 2008 May; 117(18):2351-60. PubMed ID: 18443240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous H
    Wang C; Du J; Du S; Liu Y; Li D; Zhu X; Ni X
    Mol Cell Endocrinol; 2018 Oct; 474():65-73. PubMed ID: 29486221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.